EP1983062A1 - Polymorphismes de nucléotides uniques liés à la susceptibilité à une maladie cardiovasculaire - Google Patents

Polymorphismes de nucléotides uniques liés à la susceptibilité à une maladie cardiovasculaire Download PDF

Info

Publication number
EP1983062A1
EP1983062A1 EP07251633A EP07251633A EP1983062A1 EP 1983062 A1 EP1983062 A1 EP 1983062A1 EP 07251633 A EP07251633 A EP 07251633A EP 07251633 A EP07251633 A EP 07251633A EP 1983062 A1 EP1983062 A1 EP 1983062A1
Authority
EP
European Patent Office
Prior art keywords
polymorphic
cvda
cardiovascular disease
individual
certain embodiments
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP07251633A
Other languages
German (de)
English (en)
Inventor
Monika Stoll
Gerd Assmann
Stephan Schwers
Christoph Petry
Helmut Schulte
Werner Kroll
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Siemens Healthcare Diagnostics Inc
Original Assignee
Siemens Healthcare Diagnostics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Siemens Healthcare Diagnostics Inc filed Critical Siemens Healthcare Diagnostics Inc
Priority to EP07251633A priority Critical patent/EP1983062A1/fr
Priority to US12/019,651 priority patent/US20080233582A1/en
Priority to PCT/EP2008/054562 priority patent/WO2008128930A1/fr
Publication of EP1983062A1 publication Critical patent/EP1983062A1/fr
Withdrawn legal-status Critical Current

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/156—Polymorphic or mutational markers
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/172—Haplotypes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Analytical Chemistry (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Pathology (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
EP07251633A 2005-07-26 2007-04-18 Polymorphismes de nucléotides uniques liés à la susceptibilité à une maladie cardiovasculaire Withdrawn EP1983062A1 (fr)

Priority Applications (3)

Application Number Priority Date Filing Date Title
EP07251633A EP1983062A1 (fr) 2007-04-18 2007-04-18 Polymorphismes de nucléotides uniques liés à la susceptibilité à une maladie cardiovasculaire
US12/019,651 US20080233582A1 (en) 2005-07-26 2008-01-25 Single nucleotide polymorphisms associated with susceptibility to cardiovascular disease
PCT/EP2008/054562 WO2008128930A1 (fr) 2007-04-18 2008-04-15 Polymorphismes de nucléotides simples associés à la susceptibilité pour la maladie cardiovasculaire

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP07251633A EP1983062A1 (fr) 2007-04-18 2007-04-18 Polymorphismes de nucléotides uniques liés à la susceptibilité à une maladie cardiovasculaire

Publications (1)

Publication Number Publication Date
EP1983062A1 true EP1983062A1 (fr) 2008-10-22

Family

ID=38477305

Family Applications (1)

Application Number Title Priority Date Filing Date
EP07251633A Withdrawn EP1983062A1 (fr) 2005-07-26 2007-04-18 Polymorphismes de nucléotides uniques liés à la susceptibilité à une maladie cardiovasculaire

Country Status (2)

Country Link
EP (1) EP1983062A1 (fr)
WO (1) WO2008128930A1 (fr)

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6342357B1 (en) * 1999-08-09 2002-01-29 University Of Utah Research Foundation Alterations in the long QT syndrome genes KVLQT1 and SCN5A and methods for detecting same
WO2004035746A2 (fr) * 2002-10-17 2004-04-29 Decode Genetics Ehf. Gene de susceptibilite d'un infarctus du myocarde

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6342357B1 (en) * 1999-08-09 2002-01-29 University Of Utah Research Foundation Alterations in the long QT syndrome genes KVLQT1 and SCN5A and methods for detecting same
WO2004035746A2 (fr) * 2002-10-17 2004-04-29 Decode Genetics Ehf. Gene de susceptibilite d'un infarctus du myocarde

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
SPIAWSKI I ET AL: "SPECTRUM OF MUATIONS IN LONG-QT SYNDROME GENES KVLQT1, HERG, SCN5A, KCNE1, AND KCNE2", CIRCULATION, AMERICAN HEART ASSOCIATION, DALLAS, TX, US, vol. 102, no. 10, 5 September 2000 (2000-09-05), pages 1178 - 1185, XP001070986, ISSN: 0009-7322 *
THE SANGER CENTRE (UK) AND THE WASHINGTON UNIVERSITY GENOME SEQUENCING CENTER (USA): "Toward a complete human genome sequence", GENOME RESEARCH, vol. 8, no. 11, November 1998 (1998-11-01), pages 1097 - 1108, XP002451612, ISSN: 1088-9051 *

Also Published As

Publication number Publication date
WO2008128930A1 (fr) 2008-10-30

Similar Documents

Publication Publication Date Title
JP6448149B2 (ja) 肝線維症に関連する遺伝的多型、その検出方法および使用
JP6105765B2 (ja) 脳卒中に関連した遺伝子遺伝子多型およびその検出方法および使用
JP6157571B2 (ja) スタチンの応答および心血管疾患に関連する遺伝子多型、その検出方法ならびに使用
US20230100271A1 (en) Genetic polymorphisms associated with cardiovascular diseases, methods of detection and uses thereof
JP5409658B2 (ja) 静脈血栓症に関連した遺伝子多型、その検出方法および使用
US20160271214A1 (en) Methods of treating heart failure with agonists of hypocretin receptor 2
US20090138204A1 (en) Single nucleotide polymorphisms sensitively predicting adverse drug reactions (ADR) and drug efficacy
JP2013078314A (ja) 冠動脈心疾患に関連する遺伝的多型、その検出方法および使用
US20080233582A1 (en) Single nucleotide polymorphisms associated with susceptibility to cardiovascular disease
WO2003029486A2 (fr) Polymorphismes a nucleotide unique pronostiquant les maladies cardio-vasculaires
WO2007014338A2 (fr) Polymorphismes de nucleotides uniques a susceptibilite par rapport a une maladie cardio-vasculaire
JP5601685B2 (ja) Ａｐｏ（ａ）遺伝子における多型はアセチルサリチル酸治療に対する応答性を予測する
EP1983062A1 (fr) Polymorphismes de nucléotides uniques liés à la susceptibilité à une maladie cardiovasculaire
JP2010528262A5 (fr)
WO2013061342A1 (fr) Variants conférant un risque d'anévrisme intracrânial et d'anévrisme de l'aorte abdominale
US20060240421A1 (en) Genetic polymorphisms sensitively predicting adverse drug reactions (adr) and drug efficacy
WO2005117859A2 (fr) Diagnostic d'affection cardiovasculaire
WO2007038155A2 (fr) Methodes de diagnostic d'une maladie cardiovasculaire
US8080374B2 (en) Methods of diagnosing cardiovascular disease
US20090208967A1 (en) Genetic Polymorphisms As Predictive Diagnostics For Adverse Drug Reactions (ADR) And Drug Efficacy

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU LV MC MT NL PL PT RO SE SI SK TR

AX Request for extension of the european patent

Extension state: AL BA HR MK RS

AKX Designation fees paid
STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20090423

REG Reference to a national code

Ref country code: DE

Ref legal event code: 8566